The Oncology Institute, Inc. (NASDAQ:TOI) Q1 2022 Earnings Conference Call May 11, 2022 5:00 PM ET

Company Participants

Mihir Shah – Chief Financial Officer

Brad Hively – Chief Executive Officer

Conference Call Participants

Brian Tanquilut – Jefferies

Gary Taylor – Cowen

Operator

Good afternoon and welcome to The Oncology Institute's First Quarter 2022 Earnings Conference Call. Today's call is being recorded and we have allocated one hour for prepare marks and Q&A.

At this time, I'd like to turn the conference over to Mihir Shah, Chief Financial Officer at TOI. Thank you. You may begin.

Mihir Shah

Good afternoon, everyone, and thanks for joining us to discuss to TOI's first quarter 2022 results. Before we begin, we would like to remind you that this conference call will include forward-looking statements. These statements include our future expectations regarding financial results and guidance, market opportunities and our growth. These statements are subjected to various risks, uncertainties and assumptions that could cause our actual results to differ materially from these statements.

These risks, uncertainties and assumptions are detailed in this afternoon's press release, as well as our filings with the SEC, including our registration statement on Form S-1 that was filed with the SEC, and the Form 10-Q, all of which can be found on our website at investors.theoncologyinstitute.com. We undertake no obligations to revise or update any forward-looking statements or information except as required by law.

During our call today, we will also reference certain non-GAAP financial information, including adjusted EBITDA, free cash flow and adjusted diluted EPS. We use non-GAAP measures in some of our financial discussions, as we believe they more accurately represent the true operational performance and underlying results of our business. The presentation of this non-GAAP financial information is not intended to be considered in isolation, or as a substitute for or superior to the financial information prepared and presented in accordance with GAAP. Please note that our non-GAAP measures may be different from non-GAAP measures used by other companies. Reconciliations of GAAP to non GAAP measures as well as the description limitations and rationale of using each measure can be found in this afternoon’s press release and our SEC filings.

Joining me on the call today, is our CEO, Brad Hively. Following the prepared remarks we will open the call for your questions.

With that I’ll turn the call over to Brad.

Brad Hively

Thanks, Mihir. And welcome to the team. Mihir joined TOI on April 1 and brings more than 18 years of healthcare experience from both the payor and the provider side.